Skip to main content

Peer Review reports

From: Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathway

Original Submission
1 Feb 2023 Submitted Original manuscript
31 May 2023 Reviewed Reviewer Report - Nobendu Mukerjee
1 Jun 2023 Reviewed Reviewer Report
3 Jun 2023 Reviewed Reviewer Report
4 Jun 2023 Reviewed Reviewer Report
26 Jun 2023 Author responded Author comments - Wanguo Yu
2 Jul 2023 Author responded Author comments - Wanguo Yu
Resubmission - Version 2
26 Jun 2023 Submitted Manuscript version 2
8 Jul 2023 Reviewed Reviewer Report
19 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
30 Jul 2023 Editorially accepted
16 Aug 2023 Article published 10.1186/s12906-023-04110-9

You can find further information about peer review here.

Back to article page